Clinical Trials Directory

Trials / Completed

CompletedNCT04051294

The Effect of Kombucha on Blood Sugar Levels in Humans

A Clinical Trial to Measure the Biochemical Response of Kombucha Tea in Humans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.

Detailed description

Consumption of kombucha, a fermented tea beverage, has been promoted for a wide range of health benefits. However, a systematic literature review (Kapp \& Sumner, 2019) revealed a lack of evidence for human health benefit. Despite the lack of evidence, U.S. retail sales of kombucha and other fermented beverages have increased 37.4% in 2017, and kombucha is the fastest growing product in the functional beverage market. As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans. We plan for 20 subjects to take part in this study. This is a randomized-controlled counter-balanced study design. Subjects will be asked to complete 4 in-person visits over 2 months time (twice per month). At the first visit, subjects will be randomized into one of four groups. At each subsequent visit, subjects will be randomized into one of the remaining groups until they have completed each arm. Arms (at least 5 subjects in each arm, minimum total=20 subjects) 1. Intervention group 1: commercial kombucha: drink 8oz kombucha 2. Intervention group 2: brewed kombucha: drink 8oz kombucha 3. Control group: drink 8oz tea (the same type as used to brew the kombucha) 4. Control group 2: drink 8oz tap water

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCommercial kombucha teaCommercially-available kombucha tea.
DIETARY_SUPPLEMENTBrewed kombucha teaKombucha tea brewed
OTHERControl: TeaTea brewed in our lab.
OTHERControl: WaterTap water

Timeline

Start date
2019-01-03
Primary completion
2022-09-30
Completion
2022-09-30
First posted
2019-08-09
Last updated
2023-09-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04051294. Inclusion in this directory is not an endorsement.